• Users Online: 1147
  • Print this page
  • Email this page
Year : 2021  |  Volume : 15  |  Issue : 2  |  Page : 157-165

Immunosuppression in lung transplantation: Changing perspectives

1 Institute of Heart and Lung Transplant, KIMS Hospital, Secunderabad, Telangana; Department of Heart and Lung Transplant, Gleneagles Global Hospital, Mumbai, Maharashtra, India
2 Institute of Heart and Lung Transplant, KIMS Hospital, Secunderabad, Telangana, India

Correspondence Address:
Dr. Unmil Shah
Heart and Lung Transplant Institute, KIMS Hospitals, Minister Road, Begumpet, Secunderabad, Telangana - 500 003
Login to access the Email id

Source of Support: None, Conflict of Interest: None

DOI: 10.4103/ijot.ijot_98_20

Rights and Permissions

Lung transplantation is a definitive treatment option for select end-stage lung disease patients. Post lung transplantation, immunosuppression plays a significant role in a successful outcome. Rejection and infection are commonly encountered where immunosuppression plays an important role. Many immunosuppressive strategies have been designed and their protocols might vary from center to center. This review will focus on these perspectives as well as emerging perspectives during COVID times.

Print this article     Email this article
 Next article
 Previous article
 Table of Contents

 Similar in PUBMED
   Search Pubmed for
   Search in Google Scholar for
 Related articles
 Citation Manager
 Access Statistics
 Reader Comments
 Email Alert *
 Add to My List *
 * Requires registration (Free)

 Article Access Statistics
    PDF Downloaded105    
    Comments [Add]    
    Cited by others 2    

Recommend this journal